Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT02224118 · COMPLETED

Trial details

NCT number: NCT02224118
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Diabetes Mellitus, Type 2

Start date: 2009-07-01
Primary completion: 2010-03-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.